A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women | Genetics and Genomics | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Orentreich  N.  Pathogenesis of alopecia.  J Soc Cosmet Chem. 1960;11:479-499.Google Scholar
Yi  SM, Son  SW, Lee  KG,  et al.  Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population.  Br J Dermatol. 2012;167(2):306-313.PubMedGoogle ScholarCrossref
Trüeb  RM.  Molecular mechanisms of androgenetic alopecia.  Exp Gerontol. 2002;37(8-9):981-990.PubMedGoogle ScholarCrossref
Dusková  M, Cermáková  I, Hill  M, Vanková  M, Sámalíková  P, Stárka  L.  What may be the markers of the male equivalent of polycystic ovary syndrome?  Physiol Res. 2004;53(3):287-294.PubMedGoogle Scholar
Yip  L, Rufaut  N, Sinclair  R.  Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know.  Australas J Dermatol. 2011;52(2):81-88.PubMedGoogle ScholarCrossref
Dusková  M, Stárka  L.  The existence of a male equivalent of the polycystic ovary syndrome: the present state of the issue.  Prague Med Rep. 2006;107(1):17-25.PubMedGoogle Scholar
Stárka  L, Cermáková  I, Dusková  M, Hill  M, Dolezal  M, Polácek  V.  Hormonal profile of men with premature balding.  Exp Clin Endocrinol Diabetes. 2004;112(1):24-28.PubMedGoogle ScholarCrossref
Moura  HH, Costa  DL, Bagatin  E, Sodré  CT, Manela-Azulay  M.  Polycystic ovary syndrome: a dermatologic approach.  An Bras Dermatol. 2011;86(1):111-119.PubMedGoogle ScholarCrossref
Hamilton  JB.  Patterned loss of hair in man; types and incidence.  Ann N Y Acad Sci. 1951;53(3):708-728.PubMedGoogle ScholarCrossref
Norwood  OT.  Male pattern baldness: classification and incidence.  South Med J. 1975;68(11):1359-1365.PubMedGoogle ScholarCrossref
Trüeb  RM, Lee  W-S.  Male Alopecia: Guide to Successful Management. Cham, Switzerland: Springer International Publishing; 2014.
Sinclair  RD, Dawber  RP.  Androgenetic alopecia in men and women.  Clin Dermatol. 2001;19(2):167-178.PubMedGoogle ScholarCrossref
Gopinath  H, Upadya  GM.  Metabolic syndrome in androgenic alopecia  [Epub ahead of print].  Indian J Dermatol Venereol Leprol. 2016.PubMedGoogle Scholar
Matilainen  V, Koskela  P, Keinänen-Kiukaanniemi  S.  Early androgenetic alopecia as a marker of insulin resistance.  Lancet. 2000;356(9236):1165-1166.PubMedGoogle ScholarCrossref
McDonough  PH, Schwartz  RA.  Adolescent androgenic alopecia.  Cutis. 2011;88(4):165-168.PubMedGoogle Scholar
Narad  S, Pande  S, Gupta  M, Chari  S.  Hormonal profile in Indian men with premature androgenetic alopecia.  Int J Trichology. 2013;5(2):69-72.PubMedGoogle ScholarCrossref
Stárka  L, Dusková  M, Cermakova  I, Vrbiková  J, Hill  M.  Premature androgenic alopecia and insulin resistance: male equivalent of polycystic ovary syndrome?  Endocr Regul. 2005;39(4):127-131.PubMedGoogle Scholar
Mohamed  NE, Elkhazragy  YA, Tawfeek  NAE, Hammad  WA.  Early androgenetic alopecia as a predictor of ischemic heart disease.  Am J Dermatol Venereol. 2015;4(2):18-25.Google Scholar
Chakrabarty  S, Hariharan  R, Gowda  D, Suresh  H.  Association of premature androgenetic alopecia and metabolic syndrome in a young Indian population.  Int J Trichology. 2014;6(2):50-53.PubMedGoogle ScholarCrossref
Mumcuoglu  C, Ekmekci  TR, Ucak  S.  The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia.  Eur J Dermatol. 2011;21(1):79-82.PubMedGoogle Scholar
Matthews  DR, Hosker  JP, Rudenski  AS, Naylor  BA, Treacher  DF, Turner  RC.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;28(7):412-419.PubMedGoogle ScholarCrossref
Al Kindi  MK, Al Essry  FS, Al Essry  FS, Mula-Abed  WA.  Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism.  Oman Med J. 2012;27(6):471-474.PubMedGoogle ScholarCrossref
Schmidt  JB.  Hormonal basis of male and female androgenic alopecia: clinical relevance.  Skin Pharmacol. 1994;7(1-2):61-66.PubMedGoogle ScholarCrossref
Yildiz  BO, Yarali  H, Oguz  H, Bayraktar  M.  Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2003;88(5):2031-2036.PubMedGoogle ScholarCrossref
Legro  RS, Kunselman  AR, Demers  L, Wang  SC, Bentley-Lewis  R, Dunaif  A.  Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2002;87(5):2134-2138.PubMedGoogle ScholarCrossref
Cohen  PN, Givens  JR, Wiser  WL,  et al.  Polycystic ovarian disease, maturation arrest of spermiogenesis, and Klinefelter’s syndrome in siblings of a family with familial hirsutism.  Fertil Steril. 1975;26(12):1228-1238.PubMedGoogle ScholarCrossref
Original Investigation
September 2016

A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women

Author Affiliations
  • 1Department of Dermatology and Sexually Transmitted Diseases, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
  • 2Department of Biochemistry, Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
JAMA Dermatol. 2016;152(9):986-991. doi:10.1001/jamadermatol.2016.1776

Importance  Early androgenetic alopecia (AGA) is patterned hair loss occurring before age 30 years. Early AGA in men is frequently reported as the phenotypic equivalent of polycystic ovarian syndrome (PCOS) in women, which carries the risk of developing obesity, metabolic syndrome, and cardiovascular diseases. Very few studies have been conducted to evaluate this.

Objective  To study the hormonal profile of men with early AGA and to evaluate if early AGA in men can be considered as the phenotypic equivalent of PCOS, the associated risks of which are well known.

Design, Setting, and Participants  This case-control study was conducted from January 1, 2014, to March 31, 2015, in a tertiary care government hospital. Fifty-seven men aged 19 to 30 years presenting with patterned hair loss were recruited as study participants. Thirty-two age-matched men with no evidence of hair loss were recruited as controls. Men who had any established endocrine disorder, diabetes mellitus, or cardiovascular disease and those who took any oral medication or hormonal treatment for hair loss were excluded from the study. The serum concentrations of total testosterone, sex hormone–binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, fasting plasma glucose, and insulin levels were measured. Insulin resistance (IR) and free androgen index (FAI) were calculated and compared with age- and sex-matched controls.

Main Outcomes and Measures  The primary outcome was to measure the clinico-endocrinological profiles (LH, FSH, SHBG, DHEAS, and testosterone levels) of men with early AGA and to compare it with the PCOS profile; the secondary outcome was to establish a relationship between this endocrinological profile and IR.

Results  Compared with the 32 controls, the 57 participants with AGA showed significantly increased mean (SD) levels of testosterone (24.61 [7.97] vs 20.57 [4.9] nmol/L; P = .04), DHEAS (3.63 [2.19] vs 2.64 [1.49] µg/mL; P = .02), LH (7.78 [3.19] vs 4.56 [2.01] mIU/mL; P < .001), and prolactin (14.14 [9.48] vs 9.97 [3.12] ng/mL; P = .01) and decreased mean levels of FSH (4.02 [2.69] vs 5.66 [1.93] mIU/mL; P < .001) and SHBG (35.07 [11.11] vs 46.41 [14.03] nmol/L; P < .001). The mean FAI and LH/FSH ratio were was also increased in the AGA group. These hormonal parameters resemble the well-known profile of women with PCOS. The mean (SD) insulin levels did not show any significant difference between the cases and controls (6.34 [3.92] vs 5.09 [3.38] μIU/mL; P = .07). There was no statistically significant association between hormone levels and AGA or IR grade severity.

Conclusions and Relevance  Men with early AGA could be considered as male phenotypic equivalents of women with PCOS. They can be at risk of developing the same complications associated with PCOS, including obesity, metabolic syndrome, IR, cardiovascular diseases, and infertility.